FB Pixel no scriptRecent | KrASIA
MENU
KrASIA

Most Recent

  • As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.

    Insights

    After Hengrui’s USD 500 million deal with GSK, which biotech firms are next in line?

    6 mins read